News
Public · Published
Acadia Healthcare Company, Inc. reports results for the quarter ended September 30 - Earnings Summary
Acadia Healthcare reported adjusted earnings of 60 cents per share for the quarter ended September 30, down from 72 cents a year earlier but above analysts' 46-cent average estimate. Revenue rose 5.1% to $895.31 million, exceeding expectations of $877.79 million; reported EPS was 38 cents and net income was $34.49 million.
Published:
Updated:
What happened
Acadia Healthcare reported adjusted earnings of 60 cents per share for the quarter ended September 30, down from 72 cents a year earlier but above analysts’ 46-cent average estimate. Revenue rose 5.1% to $895.31 million, exceeding expectations of $877.79 million; reported EPS was 38 cents and net income was $34.49 million.
Confirmed
Global impact / market context
The results point in different directions: revenue growth and earnings above forecasts suggest stronger performance than analysts expected, while lower adjusted earnings than a year earlier show pressure on profit per share. If that weakness continues, it could limit the cash Acadia can retain or invest in its healthcare facilities.
Analyst inference
Analysts’ average earnings estimate had fallen about 2.8% over three months, although the reported adjusted figure beat their average forecast. The shares had gained 108.7% so far this year, while the average analyst rating remained “buy”; neither fact guarantees future gains.
Confirmed
What to watch
- Future quarterly results can show whether revenue growth continues and whether adjusted earnings recover from the year-earlier level, helping clarify the balance between business growth and profit pressure. Analyst inference
- Analysts may revise earnings forecasts after comparing the reported results with expectations; further downward changes could signal concern about future profits, while upward changes would suggest improved expectations. Analyst inference
- The article reports a $32.50 median 12-month analyst price target and a $29.62 last closing price, but does not establish that either level will be reached. Confirmed
Evidence
- Original source link unavailable